Arkolith/Insider Trading/RCKT/Form 4

Militello John

See RemarksROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed May 28, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
17
0 non-derivative · 17 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 26, 2026Disposed to issuer(D)10K——0
May 26, 2026Disposed to issuer(D)10K——0
May 26, 2026Disposed to issuer(D)20K——0
May 26, 2026Disposed to issuer(D)10K——0
May 26, 2026Disposed to issuer(D)20K——0
May 26, 2026Disposed to issuer(D)2K——0
May 26, 2026Disposed to issuer(D)18K——0
May 26, 2026Disposed to issuer(D)18K——0
May 26, 2026Disposed to issuer(D)27K——0
May 26, 2026Disposed to issuer(D)29K——0
May 26, 2026Disposed to issuer(D)50K——0
May 26, 2026Disposed to issuer(D)25K——0
May 26, 2026Grant(A)52K——52K
May 26, 2026Grant(A)15K——15K
May 26, 2026Grant(A)16K——16K
May 26, 2026Grant(A)25K——25K
May 26, 2026Grant(A)9K——9K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-023153) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ROCKET PHARMACEUTICALS, INC.

Build

Ask your agent about RCKT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001140361-26-023153"
Ask your agent
Use Arkolith to summarize insider buying and selling at ROCKET PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.